Why BGPT?
logo

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review paper


     Quick Explanation



    The 2017 Scientific Reports study by Phan et al. compares Flp-mediated RMCE with CRISPR/Cas9 HDR for transgene insertion at identical lentiviral landing pads in CHO cells, finding Cas9 superior for multi-locus targeting (>80% dual-locus events vs ~20% for RMCE) but prone to aberrant insertions at cut sites (2/12 clones). Both methods achieved comparable overall targeting efficacy, with RMCE offering drug-free, promoter/ATG-trap-based isolation of correctly integrated clones.


     Long Explanation



    Study Design and Core Findings

    Phan, Contzen, Seemann, and Gossen established a CHO landing-pad system (CHO.S15 single-copy; CHO.S18 dual-copy) via lentiviral transduction, then compared Flp-RMCE against CRISPR/Cas9 HDR at the same loci . The RMCE design uses a promoter/ATG-trap: FRT sites embedded in the GFP ORF of the landing pad allow RFP reconstitution only upon in-frame cassette exchange, enabling drug-free selection by fluorescence alone.

    Strengths and Mechanistic Insight

    The 20-fold increase in hBMP-2 secretion after Cre-mediated RFP deletion (19-fold by ELISA, p<0.0001) is a striking and reproducible observation, also seen with hOct4 in an unrelated cell line, suggesting transcriptional interference between tandem promoters as a plausible mechanism . Multi-locus superiority of Cas9 is mechanistically consistent with the double-strand break acting independently at each copy, whereas RMCE requires Flp to act sequentially at two separate chromosomal sites.

    Limitations and Blind Spots

    Two of twelve "successful" HDR clones harbored irregular insertions (hamster genomic DNA or plasmid fragments) adjacent to the cut site, echoing known CRISPR aberrant-recombination phenomena . The study is limited to CHO-K1 cells, a single landing pad, and semi-quantitative flow cytometry comparisons with no systematic stability or off-target analysis. Falsification would require showing that the dual-locus advantage of Cas9 disappears under optimized donor:nuclease ratios or in other cell types, an avenue the authors themselves acknowledge as untested. Sample sizes are small (12 clones, n=3 for flow cytometry), and no genome-wide off-target assessment was performed, so the "comparable efficacy" conclusion rests on a narrow experimental window .

    Context and Continuing Relevance

    Flp recombinase remains valuable for landing-pad strategies because it requires no host repair machinery, acting as a "mild" genotoxic process relative to Cas9-induced double-strand breaks. Recent Flp engineering (photocaged variants with >98% activation in C. elegans) continues to expand its spatiotemporal control , while Cas9 engineering via directed evolution continues to broaden PAM compatibility . The Phan et al. comparison thus remains a useful decision framework: RMCE for stable, homogeneous production lines; Cas9 for multi-locus or de novo engineering without pre-built landing pads.



    Feedback:    

    Updated: October 25, 2026

     BGPT Paper Review



    Study Novelty

    60%

    First direct side-by-side Flp-RMCE vs Cas9-HDR comparison at identical landing pads; conceptually incremental but practically novel for cell-line engineering in 2017.



    Scientific Quality

    80%

    Rigorous experimental design with PCR and NGS validation; limited by small clone numbers, single cell type, semi-quantitative comparisons, and no genome-wide off-target or long-term stability analysis.



    Study Generality

    60%

    Findings are CHO-specific but the mechanistic logic (DSB independence vs sequential recombination) generalizes to other mammalian systems.



    Study Usefulness

    70%

    Directly guides choice between RMCE and Cas9 HDR for bioproduction and cell-line engineering workflows.



    Study Reproducibility

    70%

    Detailed methods with specific plasmids (Addgene IDs), transfection conditions, and PCR primer strategies support replication, though data only available on request.



    Explanatory Depth

    60%

    Clear mechanistic rationale for multi-locus difference, but the 20-fold BMP-2 expression boost remains partially unexplained.


    🎁 Authors: Collect 169 Free Science Tokens (β‰ˆ $16.9 USD)

    Claim My Author Tokens

    Use for 42 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $16.9 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Metabolic burden from RFP expression explains the 19-fold BMP-2 boost: authors explicitly reject this because growth parameters were unchanged and the effect persists in an unrelated cell line with a different GOI.

     Science Art


    Paper Review: Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT